ID
38075
Description
BACKGROUND: Currently, there is no proven pharmacologic treatment for patients with the acute respiratory distress syndrome (ARDS). Great interest remains in the use of corticosteroids for the salvage of patients with severe acute lung injury in the early phase of their disease process, a situation that that has not been evaluated in most published trials. Dexamethasone has never been evaluated in ARDS in a randomized controlled fashion. HYPOTHESIS AND OBJECTIVES: The investigators hypothesize that adjunctive treatment with intravenous dexamethasone of patients with established ARDS might change the pulmonary and systemic inflammatory response and thereby will increase the number of ventilator-free days and will decrease the extremely high overall mortality. Our goal is to examine the effects of dexamethasone on length of duration of mechanical ventilation (assessed by number of ventilator-free days) and on mortality, in patients admitted into a network of Spanish intensive care units (ICUs) who still meet ARDS criteria at 24 hours after ARDS onset.
Keywords
Versions (1)
- 9/15/19 9/15/19 -
Copyright Holder
Dr. Negrin University Hospital
Uploaded on
September 15, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Dexamethasone for Acute Respiratory Distress Syndrome NCT01731795
Eligibility Criteria
- StudyEvent: ODM
Description
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Description
Pregnant or Lactating
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0043210
- UMLS CUI [1,2]
- C0032961
- UMLS CUI [2,1]
- C0043210
- UMLS CUI [2,2]
- C0006147
Description
Other treatment protocol
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C1517586
- UMLS CUI [1,3]
- C0040808
- UMLS CUI [1,4]
- C0521115
Description
Brain death
Data type
boolean
Alias
- UMLS CUI [1]
- C0006110
Description
Terminal stage cancer or disease
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0205088
- UMLS CUI [1,2]
- C0006826
- UMLS CUI [2,1]
- C0205394
- UMLS CUI [2,2]
- C0679247
Description
Do-not-rescuitate orders
Data type
boolean
Alias
- UMLS CUI [1]
- C0079252
Description
Immunocompromised
Data type
boolean
Alias
- UMLS CUI [1]
- C0085393
Description
Corticosteroids or immunosuppressive drugs
Data type
boolean
Alias
- UMLS CUI [1]
- C0239126
- UMLS CUI [2]
- C0021081
Description
24 hours since onset elasped
Data type
boolean
Alias
- UMLS CUI [1,1]
- C4699705
- UMLS CUI [1,2]
- C0687676
- UMLS CUI [1,3]
- C0243161
- UMLS CUI [1,4]
- C1550543
- UMLS CUI [1,5]
- C0332152
- UMLS CUI [1,6]
- C1511481
- UMLS CUI [1,7]
- C0205265
- UMLS CUI [1,8]
- C0087153
- UMLS CUI [1,9]
- C4533435
Description
COPD
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0205082
- UMLS CUI [1,2]
- C0024117
Description
Congestive Heart Failure
Data type
boolean
Alias
- UMLS CUI [1]
- C0018802
Similar models
Eligibility Criteria
- StudyEvent: ODM
C0035222 (UMLS CUI [1,2])
C0683983 (UMLS CUI [1,3])
C0243161 (UMLS CUI [1,4])
C0199470 (UMLS CUI [2])
C1519316 (UMLS CUI [1,2])
C0030705 (UMLS CUI [1,3])
C0009797 (UMLS CUI [2,1])
C1519316 (UMLS CUI [2,2])
C0030701 (UMLS CUI [2,3])
C0032961 (UMLS CUI [1,2])
C0043210 (UMLS CUI [2,1])
C0006147 (UMLS CUI [2,2])
C1517586 (UMLS CUI [1,2])
C0040808 (UMLS CUI [1,3])
C0521115 (UMLS CUI [1,4])
C0006826 (UMLS CUI [1,2])
C0205394 (UMLS CUI [2,1])
C0679247 (UMLS CUI [2,2])
C0021081 (UMLS CUI [2])
C0687676 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
C1550543 (UMLS CUI [1,4])
C0332152 (UMLS CUI [1,5])
C1511481 (UMLS CUI [1,6])
C0205265 (UMLS CUI [1,7])
C0087153 (UMLS CUI [1,8])
C4533435 (UMLS CUI [1,9])
C0024117 (UMLS CUI [1,2])